Johnson & Johnson JNJ Orthopaedics Restructuring Plan — Restructuring

Other segment segments

Similar metrics at other companies

STEHealthcare — Restructuring expense incurred since Plan inception

$8.47M—

STECorporate and Other member — Restructuring expenses

$10K—

STEHealthcare Member — Restructuring Charges

$33.82M—

IR

IRMedical — Restructuring And Related Cost Cost Incurred To Date1

$3.2M—

TPRCoach — Restructuring Costs

$5.5M—

STEHealthcare and Life Sciences — Restructuring expenses

$4.75M—

Questions, answered.

What is Johnson & Johnson's orthopaedics restructuring plan — restructuring?

Johnson & Johnson (JNJ) reported orthopaedics restructuring plan — restructuring of $76.75M in Q4 2025.

What does orthopaedics restructuring plan — restructuring mean?

The total financial costs incurred to reorganize and improve the operational efficiency of the orthopaedics business segment.

How do you interpret orthopaedics restructuring plan — restructuring?

An increase in restructuring costs typically signals a major strategic pivot or effort to reduce long-term overhead, while a decrease suggests the completion of the transformation phase.

How does orthopaedics restructuring plan — restructuring compare across companies?

Similar to 'Restructuring Charges' or 'Transformation Costs' reported by medical device peers like Stryker or Zimmer Biomet when they undergo significant operational realignments.